Medicine and HealthBiologicals
Comparison of AstraZeneca and Sinopharm vaccines as boosters in protection against COVID-19 infection
A. Letafati, N. Eyvazzadeh, et al.
As COVID-19 cases surge past 640 million, the efficacy of vaccination strategies remains crucial. This study by Arash Letafati and colleagues explores the impact of various booster doses on patient outcomes, revealing that a mixed vaccine approach could reduce symptoms and hospitalization rates. Discover how combining different vaccines may enhance protection against severe infections.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US
F. S, W. C, et al.
Medicine and Health
Effectiveness of BA.1-and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan
T. Arashiro, Y. Arima, et al.
Education
Quality of instructor, fear of COVID-19, and students' anxiety as predictors of student satisfaction and academic effort in online classes
I. P. Bajs, V. Bazdan, et al.
Health and Fitness
Comparing role of religion in perception of the COVID-19 vaccines in Africa and Asia Pacific
S. Jin, A. R. Cook, et al.
